Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland

PloS One
Themba G GinindzaEllinor Östensson

Abstract

Human papillomavirus (HPV) has proven to be the cause of several severe clinical conditions on the cervix, vulva, vagina, anus, oropharynx and penis. Several studies have assessed the costs of cervical lesions, cervical cancer (CC), and genital warts. However, few have been done in Africa and none in Swaziland. Cost analysis is critical in providing useful information for economic evaluations to guide policymakers concerned with the allocation of resources in order to reduce the disease burden. A prevalence-based cost of illness (COI) methodology was used to investigate the economic burden of HPV-related diseases. We used a top-down approach for the cost associated with hospital care and a bottom-up approach to estimate the cost associated with outpatient and primary care. The current study was conducted from a provider perspective since the state bears the majority of the costs of screening and treatment in Swaziland. All identifiable direct medical costs were considered for cervical lesions, cervical cancer and genital warts, which were primary diagnoses during 2015. A mix of bottom up micro-costing ingredients approach and top-down approaches was used to collect data on costs. All costs were computed at the price level of 20...Continue Reading

References

Oct 3, 2002·Journal of the National Cancer Institute·Jeanne S MandelblattPaul D Blumenthal
Dec 18, 2004·Clinical Nursing Research·Jane DrummondGerard M Kysela
Jul 9, 2005·International Journal of Cancer. Journal International Du Cancer·Rosa LegoodRengaswamy Sankaranarayanan
Nov 18, 2005·The New England Journal of Medicine·Sue J GoldieUNKNOWN Alliance for Cervical Cancer Prevention Cost Working Group
May 30, 2006·Obstetrical & Gynecological Survey·Dorothy Wiley, Emmanuel Masongsong
Aug 5, 2006·Cost Effectiveness and Resource Allocation : C/E·Jeremy D Goldhaber-Fiebert, Sue J Goldie
Nov 21, 2007·Bulletin of the World Health Organization·F T CuttsL Markowitz
May 6, 2008·American Journal of Obstetrics and Gynecology·Delphine Hu, Sue Goldie
Jul 22, 2008·Vaccine·Diane M Harper, Jorma Paavonen
Dec 17, 2008·Gynecologic Oncology·Arthi VijayaraghavanChristopher Santas
Jan 6, 2010·International Journal of Cancer. Journal International Du Cancer·Carol E LevinSue J Goldie
May 28, 2011·Vaccine·I BorgetP Mathevet
Jul 1, 2011·International Journal of Cancer. Journal International Du Cancer·Nicole G CamposSue J Goldie
Apr 17, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Jeffrey Jen Hui LowSun Kuie Tay
Aug 14, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T BärnighausenJ C O'Brien
Nov 28, 2012·PloS One·Gianluca BaioGiampiero Favato
Feb 13, 2014·JAMA : the Journal of the American Medical Association·Eva HerweijerLisen Arnheim-Dahlström
Feb 19, 2015·The New England Journal of Medicine·Elmar A JouraUNKNOWN Broad Spectrum HPV Vaccine Study
Dec 23, 2015·Emerging Infectious Diseases·Ross L CameronKevin G J Pollock
Feb 10, 2016·International Journal of Cancer. Journal International Du Cancer·Eva HerweijerLisen Arnheim-Dahlström

❮ Previous
Next ❯

Citations

Jul 19, 2018·PharmacoEconomics·Kristina R DahlstromDavid R Lairson
May 18, 2018·Journal of Gynecologic Oncology·Mikio MikamiHidetaka Katabuchi
Apr 16, 2021·PloS One·Cebisile NgcamphalalaThemba G Ginindza
May 8, 2021·Health Security·Deliana KostovaRonald L Moolenaar

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
hysterectomy
X-ray

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved